177 related articles for article (PubMed ID: 37652945)
1. Long-term prognosis and overall mortality in patients with progressive multifocal leukoencephalopathy.
Kim J; Kim C; Lee JA; Lee SJ; Lee KH; Kim JH; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
Sci Rep; 2023 Aug; 13(1):14291. PubMed ID: 37652945
[TBL] [Abstract][Full Text] [Related]
2. Clinical Profile and Outcome of Progressive Multifocal Leukoencephalopathy in HIV Infected Indian Patients.
Shah V; Toshniwal H; Shevkani M
J Assoc Physicians India; 2017 Mar; 65(3):40-44. PubMed ID: 28462542
[TBL] [Abstract][Full Text] [Related]
3. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
[TBL] [Abstract][Full Text] [Related]
4. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
[TBL] [Abstract][Full Text] [Related]
6. AIDS-related progressive multifocal leukoencephalopathy in the era of HAART: report of two cases and review of the literature.
Wyen C; Lehmann C; Fätkenheuer G; Hoffmann C
AIDS Patient Care STDS; 2005 Aug; 19(8):486-94. PubMed ID: 16124842
[TBL] [Abstract][Full Text] [Related]
7. Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.
Giancola ML; Rizzi EB; Lorenzini P; Rovighi L; Baldini F; Schininà V; Larussa D; Bibbolino C; Antinori A
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):155-62. PubMed ID: 18240958
[TBL] [Abstract][Full Text] [Related]
8. Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era.
Jiang R; Song Z; Liu L; Mei X; Sun J; Qi T; Wang Z; Song W; Tang Y; Yang J; Xu S; Zhao B; Shen Y; Zhang R; Chen J
Front Cell Infect Microbiol; 2023; 13():1208155. PubMed ID: 38029233
[TBL] [Abstract][Full Text] [Related]
9. Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study.
Falcó V; Olmo M; del Saz SV; Guelar A; Santos JR; Gutiérrez M; Colomer D; Deig E; Mateo G; Montero M; Pedrol E; Podzamczer D; Domingo P; Llibre JM
J Acquir Immune Defic Syndr; 2008 Sep; 49(1):26-31. PubMed ID: 18667930
[TBL] [Abstract][Full Text] [Related]
10. Progressive multifocal leukoencephalopathy: A 25-year retrospective cohort study.
Anand P; Hotan GC; Vogel A; Venna N; Mateen FJ
Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31554669
[TBL] [Abstract][Full Text] [Related]
11. HIV-associated PML: changing epidemiology and clinical approach.
Simpson DM
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S24-7. PubMed ID: 22123930
[TBL] [Abstract][Full Text] [Related]
12. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.
Tantisiriwat W; Tebas P; Clifford DB; Powderly WG; Fichtenbaum CJ
Clin Infect Dis; 1999 May; 28(5):1152-4. PubMed ID: 10452651
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.
Wyen C; Hoffmann C; Schmeisser N; Wöhrmann A; Qurishi N; Rockstroh J; Esser S; Rieke A; Ross B; Lorenzen T; Schmitz K; Stenzel W; Salzberger B; Fätkenheuer G
J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1263-8. PubMed ID: 15385733
[TBL] [Abstract][Full Text] [Related]
14. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.
Antinori A; Ammassari A; Giancola ML; Cingolani A; Grisetti S; Murri R; Alba L; Ciancio B; Soldani F; Larussa D; Ippolito G; De Luca A
J Neurovirol; 2001 Aug; 7(4):323-8. PubMed ID: 11517411
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy.
Ferretti F; Bestetti A; Yiannoutsos CT; Musick BS; Gerevini S; Passeri L; Bossolasco S; Boschini A; Franciotta D; Lazzarin A; Cinque P
Clin Infect Dis; 2018 Jun; 67(1):65-72. PubMed ID: 29346632
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Radiological Characterization of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients: A Retrospective Analysis and Review of the Literature.
Augusto L; Neves N; Reis C; Abreu C; Sarmento A
Acta Med Port; 2015; 28(3):286-96. PubMed ID: 26421780
[TBL] [Abstract][Full Text] [Related]
18. [Progressive multifocal leukoencephalopathy in patients with AIDS: is there a change in patients treated with highly active antiretroviral therapies?].
Montes Santiago J; Pérez Fernández E; González Vázquez L; Morano Amado L; Fernández Martín J; Asorey Carballeira A; Pérez Alvarez R
An Med Interna; 2002 May; 19(5):230-3. PubMed ID: 12107996
[TBL] [Abstract][Full Text] [Related]
19. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.
Albrecht H; Hoffmann C; Degen O; Stoehr A; Plettenberg A; Mertenskötter T; Eggers C; Stellbrink HJ
AIDS; 1998 Jul; 12(10):1149-54. PubMed ID: 9677163
[TBL] [Abstract][Full Text] [Related]
20. Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy.
Marzocchetti A; Cingolani A; Giambenedetto SD; Ammassari A; Giancola ML; Cauda R; Antinori A; Luca AD
J Neurovirol; 2005 Apr; 11(2):219-24. PubMed ID: 16036800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]